RCEL
Income statement / Annual
Last year (2022), AVITA Medical, Inc.'s total revenue was $50.56 M,
an increase of 254.49% from the previous year.
In 2022, AVITA Medical, Inc.'s net income was -$39.17 M.
See AVITA Medical, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2020
|
FY-2019
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
FY-2013
|
FY-2012
|
FY-2011
|
| Period Ended |
12/31/2022 |
06/30/2021 |
06/30/2020 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
06/30/2014 |
06/30/2013 |
06/30/2012 |
| Operating Revenue |
$50.56 M
|
$14.26 M
|
$20.67 M
|
$1.26 M
|
$1.18 M
|
$1.00 M
|
$985,647.00
|
$2.68 M
|
$2.81 M
|
$3.35 M
|
| Cost of Revenue |
$8.87 M |
$2.97 M |
$4.31 M |
$737,700.00 |
$505,636.00 |
$401,568.00 |
$289,200.00 |
$670,893.00 |
$676,502.00 |
$952,847.00 |
| Gross Profit |
$41.69 M |
$11.29 M |
$16.36 M |
$517,471.00 |
$674,996.00 |
$600,439.00 |
$696,447.00 |
$2.01 M |
$2.14 M |
$2.40 M |
| Gross Profit Ratio |
0.82 |
0.79 |
0.79 |
0.41 |
0.57 |
0.6 |
0.71 |
0.75 |
0.76 |
0.72 |
| Research and Development
Expenses |
$20.35 M
|
$8.46 M
|
$13.28 M
|
$8.45 M
|
$6.27 M
|
$3.46 M
|
$3.77 M
|
$2.15 M
|
$2.60 M
|
$969,113.00
|
| General & Administrative
Expenses |
$34.27 M
|
$34.62 M
|
$46.77 M
|
$12.70 M
|
$0.00
|
$6.51 M
|
$2.45 M
|
$4.27 M
|
$5.45 M
|
$5.34 M
|
| Selling & Marketing
Expenses |
$32.19 M
|
$14.81 M
|
$22.76 M
|
$6.59 M
|
$5.20 M
|
$3.46 M
|
$3.21 M
|
$2.63 M
|
$3.39 M
|
$2.93 M
|
| Selling, General &
Administrative Expenses |
$66.46 M
|
$49.43 M
|
$70.61 M
|
$21.21 M
|
$13.90 M
|
$10.93 M
|
$5.68 M
|
$7.09 M
|
$8.92 M
|
$8.44 M
|
| Other Expenses |
$0.00 |
$686,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$80.78 M |
$53.97 M |
$77.21 M |
$19.15 M |
$13.35 M |
$11.95 M |
$9.26 M |
$8.83 M |
$10.77 M |
$10.66 M |
| Cost And Expenses |
$89.65 M |
$56.94 M |
$81.51 M |
$19.88 M |
$13.85 M |
$12.36 M |
$9.55 M |
$9.50 M |
$11.45 M |
$11.61 M |
| Interest Income |
$23,502.00 |
$0.00 |
$47,817.00 |
$28,373.00 |
$110,955.00 |
$110,343.00 |
$45,418.00 |
$160,327.00 |
$412,263.00 |
$497,989.00 |
| Interest Expense |
$0.00 |
$33,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.46 M
|
$465,000.00
|
-$0.00
|
$105,447.73
|
$139,703.00
|
$83,724.00
|
$62,624.00
|
$63,711.00
|
$121,924.00
|
$569,232.00
|
| EBITDA |
-$39.57 M
|
-$41.53 M
|
-$61.17 M
|
-$18.55 M
|
-$12.53 M
|
-$11.27 M
|
-$8.68 M
|
-$6.76 M
|
-$8.51 M
|
-$5.62 M
|
| EBITDA Ratio |
-0.78 |
-2.91 |
-2.96 |
-14.78 |
-10.61 |
-11.25 |
-8.81 |
-2.52 |
-3.02 |
-1.68 |
| Operating Income Ratio
|
-0.8
|
-2.99
|
-2.99
|
-14.9
|
-10.73
|
-11.33
|
-8.87
|
-2.54
|
-3.07
|
-1.85
|
| Total Other
Income/Expenses Net |
$1.29 M
|
$686,000.00
|
$946,197.00
|
$43,236.00
|
$110,955.00
|
$110,343.00
|
$222,968.00
|
$160,327.00
|
$412,263.00
|
-$1.57 M
|
| Income Before Tax |
-$39.12 M |
-$42.03 M |
-$60.90 M |
-$18.66 M |
-$12.56 M |
-$11.24 M |
-$8.52 M |
-$6.66 M |
-$8.22 M |
-$7.76 M |
| Income Before Tax Ratio
|
-0.77
|
-2.95
|
-2.95
|
-14.86
|
-10.64
|
-11.22
|
-8.64
|
-2.48
|
-2.92
|
-2.31
|
| Income Tax Expense |
$52,880.00 |
$4,000.00 |
$5,796.00 |
$1.45 M |
$1.05 M |
$971,881.00 |
$653,668.00 |
$1.51 M |
$128,054.00 |
$87,756.00 |
| Net Income |
-$39.17 M |
-$42.03 M |
-$60.90 M |
-$17.21 M |
-$11.51 M |
-$10.27 M |
-$7.87 M |
-$5.15 M |
-$8.09 M |
-$7.59 M |
| Net Income Ratio |
-0.77 |
-2.95 |
-2.95 |
-13.71 |
-9.75 |
-10.25 |
-7.98 |
-1.92 |
-2.87 |
-2.26 |
| EPS |
-1.57 |
-2.07 |
-3 |
-1.84 |
-1.72 |
-2.06 |
-2.23 |
-1.58 |
-2.69 |
-3.19 |
| EPS Diluted |
-1.57 |
-2.07 |
-3 |
-1.85 |
-1.72 |
-2.06 |
-2.23 |
-1.58 |
-2.69 |
-3.19 |
| Weighted Average Shares
Out |
$25.00 M
|
$20.29 M
|
$20.29 M
|
$9.30 M
|
$6.69 M
|
$4.99 M
|
$3.53 M
|
$3.25 M
|
$3.01 M
|
$2.38 M
|
| Weighted Average Shares
Out Diluted |
$25.00 M
|
$20.29 M
|
$20.29 M
|
$9.33 M
|
$6.70 M
|
$4.99 M
|
$3.53 M
|
$3.25 M
|
$3.01 M
|
$2.38 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
